113 related articles for article (PubMed ID: 9200490)
1. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth.
Jelinek DF; Witzig TE; Arendt BK
J Immunol; 1997 Jul; 159(1):487-96. PubMed ID: 9200490
[TBL] [Abstract][Full Text] [Related]
2. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
3. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.
Friend KE; Khandwala HM; Flyvbjerg A; Hill H; Li J; McCutcheon IE
Growth Horm IGF Res; 2001 Apr; 11(2):84-91. PubMed ID: 11472074
[TBL] [Abstract][Full Text] [Related]
5. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
7. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
Alexia C; Lasfer M; Groyer A
Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
9. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
Bredin CG; Liu Z; Klominek J
Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
[TBL] [Abstract][Full Text] [Related]
10. IGFs, basic FGF, and glucose modulate proliferation and apoptosis induced by IFNgamma but not by IL-1beta in rat INS-1E beta-cells.
Raile K; Berthold A; Banning U; Horn F; Pfeiffer G; Kiess W
Horm Metab Res; 2003 Jul; 35(7):407-14. PubMed ID: 12931271
[TBL] [Abstract][Full Text] [Related]
11. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
Rosendahl A; Forsberg G
Int J Oncol; 2004 Nov; 25(5):1327-36. PubMed ID: 15492822
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
14. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
[TBL] [Abstract][Full Text] [Related]
16. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
17. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
Bermont L; Fauconnet S; Lamielle F; Adessi GL
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]